SubioMed Corporation Announces Successful Completion of Financing
MINNEAPOLIS, June 24, 2020 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed™” or the “Company”), a pioneer in the invention and development of disruptive Suspension Biomechanics™ technology addressing critical elements of gait and balance, today announced that it has successfully completed its initial equity financing round of $1.5M.
The common stock offering saw insider participation, in addition to investments from individual angel investors.
Proceeds from the financing will be used to further the development of its first products which SubioMed anticipates launching in early 2021.
SubioMed intends to commercialize technology invented by Barry Butler DPM. Dr. Butler has been in practice 28 years and is board-certified by the American Board of Podiatric Surgery (ABPS) and a Fellow of the American College of Foot and Ankle Surgeons (FACFAS).
SubioMed™ is pioneering the invention and development of Suspension Biomechanics technology aimed at improving lower extremity biomechanics and its effect on the skeletal structure during human locomotion. For more information, please visit our website at www.subiomed.com.